Malbert C-H, Chauvin A, Horowitz M, et al
Without insurance coverage, Ozempic can be expensive
Semaglutide vs Tirzepatide vs Retatrutide: A Research Comparison of GLP-1 Receptor Agonist Peptides An evidence-based comparison of three incretin-based research peptides semaglutide (GLP-1), tirzepatide (GIP/GLP-1), and retatrutide (GIP/GLP-1/glucagon) covering receptor pharmacology, clinical trial data from the STEP, SURMOUNT, and Phase 2 retatrutide programs, stability considerations, and analytical quality benchmarks.
This decision is always individualized and guided by your surgeon and anesthesia team
Unlike single-pathway peptides, Retatrutide interacts with multiple hormone receptors simultaneously, enabling researchers to investigate coordinated endocrine signaling effects